This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Davidson and colleagues¹ found that sertraline, hypericum (St John's wort), and placebo had similar efficacy for treatment of depression. I agree with Kupfer and Frank,² who stated in their Editorial that the trial had low assay sensitivity. This does not simply mean low power for the primary outcome, however. It also indicates that the process and outcome of the study itself could not answer the postulated question, which is likely due to multiple small factors that enhance what Moerman and I have called the meaning or healing response.³ For example, because sertraline produced more physiological effects than placebo or hypericum, subjects were not completely blinded to treatment assignment. When physiological effects of treatment are experienced by some patients receiving an active treatment in depression studies, effect sizes are falsely elevated unless an active placebo that mimics these effects is used.⁴ Such an active placebo was not . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder
Spielmans
JAMA 2004;291:41-41.
FULL TEXT